Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Robert A. McCutcheon(Oxford Health NHS Foundation Trust), Philip McGuire(Warneford Hospital)
Cited by 684
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
|Trends in Neurosciences|2019|741
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Prevention of Psychosis
|JAMA Psychiatry|2020|463
Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow
|Neuropsychopharmacology|2003|314